Newspaper Advertisement of the Unaudited Financial Result for the Quarter ended on 30th June, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caprolactam Chemicals Ltd submitted its unaudited Q1 FY26 results to BSE via a newspaper advertisement dated 16 August 2025. Revenue from operations jumped to ₹256.56 lakhs, more than doubling from ₹112.48 lakhs in the same quarter last year. The company swung to a profit of ₹36.21 lakhs, compared to a loss of ₹26.63 lakhs in Q1 FY25, with EPS improving to ₹0.79 from negative ₹0.58. For reference, full-year FY25 revenue was ₹674.92 lakhs with a loss of ₹71.83 lakhs, and equity share capital remains at ₹460 lakhs (face value ₹10 per share). The board meeting approving these results was held on 14 August 2025.
The return to profitability and strong revenue growth are positive developments for shareholders, though the company's small scale and depleted reserves (nil in Q1 FY26 vs ₹22.85 lakhs at FY25 end) warrant continued monitoring. The news is likely to be modestly positive for the stock in the near term.